Skip to main content

Table 1 Treatment groups

From: Robenacoxib versus meloxicam for the control of peri-operative pain and inflammation associated with orthopaedic surgery in cats: a randomised clinical trial

Groups

Number of cats

s.c. dosage (mean ± SD) in mg/kg

Daily oral dosage (mean ± SD) in mg/kg*

Target

Actual

Target

Actual

Robenacoxib (s.c. + oral)

101

2.0

2.0 ± 0.09

1.0 – 2.4

1.58 ± 0.41

Meloxicam (s.c. + placebo oral)

46

0.3

0.3 ± 0.005

-

-

  1. s.c.: subcutaneous.
  2. *Robenacoxib and placebo tablets were administered once daily for 9 (range, 7–11) days.